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Text: Background 
Determining P. aeruginosa (Psae) status accurately in a nebuliser adherence study is crucial 
because Psae status influences prescription of inhaled therapies and determines normative 
adherence (Hoo ZH, et al. Patient Prefer Adherence 2016;10:1-14). 
 
Aim 
To describe how Psae status was determined in the CFHH pilot 
 
Methods 
CFHH is a NIHR-funded programme comparing a complex intervention to support self-care & 
nebuliser adherence vs standard care among adults with CF. The pilot trial ran in Nottingham 
and Southampton. 
Two data collection methods were used for Psae status: 
(1) Microbiological data for 12 months pre-recruitment were recorded and the Leeds criteria 
(Lee TW et al. JCF 2003;2:29-34) applied 
(2) Local Principal Investigators (LPI) independently decided on the Psae status 
If LPI agreed with Leeds criteria or "over-estimate" Psae status in relation to Leeds criteria, 
LPI decision was accepted as the ´final´ Psae status. If Leeds criteria suggested intermittent 
Psae but LPI suggested no Psae, Leeds criteria is accepted. If Leeds criteria suggested chronic 
Psae but LPI disagreed, this was resolved between the Chief Investigator (CI) and LPI. 
 
Results 
63 (out of 64) participants have Psae results. 
 
  Clinicians´ decision: 
Leeds criteria: No Psae Intermittent Psae Chronic Psae 
No Psae 22 1 2 
Intermittent Psae 1 4 3 
Chronic Psae 0 1 29 
[Clinicians' decision vs Leeds criteria] 
 
 
By resolving the differences between clinicians´ decision and Leeds criteria as described, 34 
participants have chronic Psae, 7 have intermittent Psae and 22 have no Psae. 
Only 1 participant required resolution of the ´final´ Psae status between CI and LPI. 
 
Conclusion 
Pragmatically determining Psae status by combining clinicians´ decision with Leeds criteria 
was easy to use and acceptable across two separate adult pilot centres, allowing Psae status to 
be determined for all participants with data. 
 
